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A 69-year-old man with persistent atrial fibrillation (AF) 
and a CHA2DS2-VAS score of 4 for age, congestive heart 
failure, arterial hypertension, and vascular disease un-
derwent left atrial appendage (LAA) closure with a LARIAT 
(SentreHEART, Inc., Redwood City, CA) device in August 
2013 due to contraindications for oral anticoagulation. 
The LARIAT device was applied using a  standard trans-
septal and subxiphoid pericardial approach with general 
endotracheal anesthesia with no intraoperative complica-
tions. Transesophageal echocardiography (TEE) confirmed 
complete LAA closure with only a small leak. The patient 
was discharged on aspirin (1 × 75 mg/day) and ibuprofen 
(3 × 200 mg/day for 7 days). Three years later, he was read-
mitted because of unstable angina. Coronary angiography 
showed multivessel disease and the patient was qualified 
for coronary artery bypass grafting (CABG). On admission, 
the patient was still on aspirin and had AF with no history 
of thromboembolic events. Transesophageal echocardiog-
raphy showed a diagnostically ambiguous, hypoechogenic 
mass, located on the lower part of the left atrium (Figure 1 A), 
small transseptal leak and complete LAA closure with no 
evidence of residual communication.
The CABG was performed with standard techniques. 
Interestingly, there was no presence of adhesions across 
the entire surface of the anterior mediastinum and no 
signs of any intervention in that region (Figure 1 B). There 
were also no adhesions in the pericardium (Figure 1 C). In-
traoperative examination revealed the presence of LARIAT 
suture tightened around the LAA, which was shrunk and 
remodeled due to postprocedural necrosis (Figure 1 D). 
The left atrium was opened to exclude the presence of 
thrombus. Intraoperative examination showed properly 
closed LAA with no pathological mass (Figure 1 E).
This is the first report to describe CABG with full me-
dian sternotomy following the LARIAT procedure. In con-
trast to endocardial approaches such as Watchman, Am-
platzer or the LAmbre delivery system, the LARIAT device 
allows the percutaneous ligation of the LAA through the 
delivery of a  suture via a  combined epicardial and epi-
cardial approach [1, 2]. Despite the high effectiveness of 
LAA closure with LARIAT [3, 4], there is a concern that the 
epicardial approach with pericardium puncture using the 
LARIAT delivery system may cause pericardial adhesion 
after the procedure. Importantly, pericardial adhesions 
may have consequences for the patient in case of the 
need for cardiac surgery. Therefore, patients often require 
anti-inflammatory therapy after the LARIAT procedure. 
Luckily, modifications of initial technique and the use of 
micropuncture needle and prophylactic colchicine has im-
proved the safety profile of this device dramatically.
Our case suggests that anti-inflammatory therapy 
after the LARIAT procedure may prevent pericardial adhe-
sion after epicardial access to the LAA. However, further 
studies are required to define the optimal dosage of ibu-
profen and treatment duration to avoid inflammation in 
the pericardium.
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Figure 1. A – Transesophageal echocardiography (TEE) performed 3 years after LARIAT procedure. Hypoecho-
genic mass in the left atrium and no residual leak from left atrial appendage (LAA) to left atrium, B – Intraop-
erative picture during coronary artery bypass grafting. Anterior mediastinum without adhesions and signs of 
any intervention after pericardial access, C – no adhesions in pericardium, D – fully excluded LAA with LARIAT 
ligation loop. Shrunk and with different color due to necrosis remodeling, E – left atrium with no thrombus or 
remaining fibrous cap
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